TL;DR: Adventris Pharmaceuticals is a Y Combinator Winter 2023 startup Adventris makes cancer vaccines, currently active with a team of 7.
Adventris makes cancer vaccines
Last verified:
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
Built by LemStudio
Yes. Adventris Pharmaceuticals was funded by Y Combinator in the Winter 2023 batch. Adventris makes cancer vaccines
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of canc…
Adventris Pharmaceuticals was part of Y Combinator's Winter 2023 batch.
Adventris Pharmaceuticals has a team of 7 people according to Y Combinator's directory.
Adventris Pharmaceuticals is currently listed as Active with a team of 7 in Y Combinator's directory.
Loading interactive view…